United States · FDA National Drug Code directory
Jafra Royal Defy Sample Kit
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68828-760_2c4bc7c6-4f80-19b9-e063-6394a90aa4f5
- Product NDC
- 68828-760
- Form
- KIT
- Composition / generic term
- Avobenzone, Homosalate, Octisalate, Octocrylene
- Labeler
- Distribuidora Comercial Jafra, S.A. de C.V.
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start / end (source format)
- 20220112
- Source listing expiry
- 20261231
Source-listed ingredients
Separate ingredient quantities are not available in this snapshot. Any composition term above is preserved as source text.
These values do not establish equivalence or a dose recommendation.
Packages
- 1 KIT in 1 KIT (68828-760-01) * 7.5 mL in 1 TUBE * 7.5 mL in 1 TUBE * 7.5 mL in 1 TUBE (68828-761-01) * 7.5 mL in 1 TUBE · 68828-760-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →